Well @Pledge wanted someone's head to roll ... lol
Doesn't look like he has gone altogether though ?
Dr Rose has been heavily involved in BARDA, the NIH etc so if the NIH is in fact funding the next COVID-19 ARDS phase 3 trial, perhaps they requested a change of CMO ?
There would be a reason for this change, however I am not sure us retail plebs will be told why ... GLTAH
Ann: Mesoblast Appoints Dr Eric Rose as Chief Medical Officer, page-10
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.57 |
Change
0.000(0.00%) |
Mkt cap ! $1.764B | |||
| Open | High | Low | Value | Volume |
| $1.56 | $1.57 | $1.52 | $1.514M | 981.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 12950 | $1.56 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.57 | 10759 | 2 |
View Market Depth
| Last trade - 11.31am 18/11/2024 (20 minute delay) ? |
| MSB (ASX) Chart |